BIOMARIN PHARMACEUTICAL INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2010 to Q3 2024.
  • Biomarin Pharmaceutical Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 197M shares, a 3.13% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 192M shares, a 1.39% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 189M shares, a 3.34% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 183M shares, a 4.61% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 197M +5.97M +3.13% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 201M +5.51M +2.82% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 199M +4.9M +2.52% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 192M +2.63M +1.39% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 191M +5.58M +3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 195M +7.55M +4.03% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 194M -523K -0.27% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 189M +6.11M +3.34% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 186M +2.38M +1.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 187M +2.02M +1.09% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 195M +10.5M +5.71% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 183M -8.83M -4.61% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 183M -14.5M -7.32% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 185M +4.7M +2.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 184M -2.8M -1.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 192M +12.6M +7.06% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 198M +11.8M +6.32% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 181M +1.68M +0.94% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 187M +8.89M +4.99% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 179M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 186M +8.44M +4.76% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 179M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 178M +2.12M +1.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q3 2018 177M +2.38M +1.36% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q1 2018 176M +3.44M +1.99% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q3 2017 175M +7.39M +4.41% Jul 1, 2017 Sep 30, 2017 10-Q 2017-10-31
Q1 2017 173M Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q3 2016 168M +6.58M +4.08% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q4 2015 160M +13.7M +9.35% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 161M +1.83M +1.15% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 160M +14.1M +9.6% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-05
Q1 2015 158M +13.5M +9.33% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-05
Q4 2014 146M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 159M +18.5M +13.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 146M +6.76M +4.84% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 144M +16.2M +12.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 141M Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 140M +21.7M +18.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 128M +12.9M +11.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q2 2012 118M +6.8M +6.12% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 115M +4.33M +3.91% Jan 1, 2012 Mar 31, 2012 10-Q 2012-04-30
Q4 2011 112M -13.6M -10.8% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 112M -19M -14.5% Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-31
Q2 2011 111M +9.28M +9.11% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-01
Q1 2011 111M +7.02M +6.77% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 126M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 131M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 102M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 104M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.